John M. Trahanas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John M. Trahanas has a total of 215 co-authors. Here are the top co-authors by number of shared publications:
Ashish S. Shah
21 shared publicationsSwaroop Bommareddi
17 shared publications- Brian Lima
Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
15 shared publications - Awab Ahmad
Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN
13 shared publications - Chen Chia Wang
Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville TN 37232
13 shared publications Kelly Schlendorf
13 shared publications
Latest Publications
- 16 October 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
The heart transplant alimony-prior scars causing future strain
- 16 October 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
The heart transplant alimony-prior scars causing future strain
- 1 October 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (10)
Donor Heart Preservation at 10 °C Outperforms 4–8 °C With Improved Early Graft Function in Adult Heart Transplantation: A Vanderbilt and Duke Multicenter Study
BACKGROUND: Static cold storage of cardiac allografts at 4–8 °C or 10 °C has yielded promising heart transplant outcomes compared with ice storage. However, direct comparisons between these 2 preservation temperatures are lacking. This dual-center study is the first to compare adult heart transplant outcomes using allografts preserved at 10 °C versus 4–8 °C static cold storage. METHODS: All single-organ, donation-after-brain-death adult heart transplants performed at 2 high-volume centers between January 2020 and April 2025 were retrospectively analyzed. Multiorgan, adult congenital, and donation-after-circulatory-death cases were excluded. A 3:1 nearest-neighbor propensity score matching was applied using a standardized mean difference P =0.004), greater donor-recipient sex mismatch, and more frequent donor undersizing by predicted heart mass ratio. Recipients in this cohort were older and had more re-sternotomies and higher serum creatinine levels at transplant. Patients in the 4–8 °C group were more often listed as Status 2. After matching, 10 °C preservation was associated with less primary graft dysfunction (2 [2.9%] versus 19 [14.6%]; P =0.008), less left and right ventricular dysfunction, reduced new intraaortic balloon pump use, and improved 1-year survival (95.7% versus 86.2%; P =0.02). Other outcomes, including cardiac indices and posttransplant length of stay, were not significantly different between groups. CONCLUSIONS: Preservation of cardiac allografts at 10 °C may yield superior early graft function compared with 4–8 °C static cold storage. However, further prospective studies are required to delineate the optimal donor heart preservation temperature.
- 1 October 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (10)
Donor Heart Preservation at 10 °C Outperforms 4–8 °C With Improved Early Graft Function in Adult Heart Transplantation: A Vanderbilt and Duke Multicenter Study
BACKGROUND: Static cold storage of cardiac allografts at 4–8 °C or 10 °C has yielded promising heart transplant outcomes compared with ice storage. However, direct comparisons between these 2 preservation temperatures are lacking. This dual-center study is the first to compare adult heart transplant outcomes using allografts preserved at 10 °C versus 4–8 °C static cold storage. METHODS: All single-organ, donation-after-brain-death adult heart transplants performed at 2 high-volume centers between January 2020 and April 2025 were retrospectively analyzed. Multiorgan, adult congenital, and donation-after-circulatory-death cases were excluded. A 3:1 nearest-neighbor propensity score matching was applied using a standardized mean difference P =0.004), greater donor-recipient sex mismatch, and more frequent donor undersizing by predicted heart mass ratio. Recipients in this cohort were older and had more re-sternotomies and higher serum creatinine levels at transplant. Patients in the 4–8 °C group were more often listed as Status 2. After matching, 10 °C preservation was associated with less primary graft dysfunction (2 [2.9%] versus 19 [14.6%]; P =0.008), less left and right ventricular dysfunction, reduced new intraaortic balloon pump use, and improved 1-year survival (95.7% versus 86.2%; P =0.02). Other outcomes, including cardiac indices and posttransplant length of stay, were not significantly different between groups. CONCLUSIONS: Preservation of cardiac allografts at 10 °C may yield superior early graft function compared with 4–8 °C static cold storage. However, further prospective studies are required to delineate the optimal donor heart preservation temperature.
- Open Access
- 28 September 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Intraoperative Goal-Directed Perfusion Improves Outcomes in Left Ventricular Assist Device Explant Heart Transplantation
Left ventricular assist device (LVAD) explant heart transplantation represents a metabolically vulnerable population with an increased risk for renal failure and mortality. Oxygen extraction ratio (O 2 ER), which integrates oxygen delivery and tissue oxygen demand, may provide a physiologic marker of cumulative metabolic stress during cardiopulmonary bypass (CPB). Adult LVAD-explant heart transplant recipients at a single center from October 2021 to June 2025 were analyzed using continuous perfusion data captured during CPB. Oxygen extraction ratio was calculated continuously, and cumulative oxygen extraction burden was quantified as the area above an O 2 ER threshold of 0.20. Patients were stratified by median O 2 ER burden. Among 110 patients, a higher intraoperative O 2 ER burden was associated with increased postoperative renal replacement therapy (odds ratio [OR], 4.16; 95% confidence interval [CI], 1.35–12.83) and increased 2-year mortality (hazard ratio [HR], 7.61; 95% CI, 1.49–38.73) after inverse probability weighting adjustment. A higher O 2 ER burden was also associated with a lower immediate postoperative cardiac index and increased vasoactive inotrope requirements. Donor hypertension, recipient diabetes, static storage modality, and a lower intraoperative oxygen delivery index were associated with an increased O 2 ER burden. These findings suggest that cumulative oxygen extraction during CPB reflects intraoperative metabolic stress and may represent a physiologically integrated perfusion target in LVAD-explant heart transplantation.
- 28 September 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Open AccessIntraoperative Goal-Directed Perfusion Improves Outcomes in Left Ventricular Assist Device Explant Heart Transplantation
Left ventricular assist device (LVAD) explant heart transplantation represents a metabolically vulnerable population with an increased risk for renal failure and mortality. Oxygen extraction ratio (O 2 ER), which integrates oxygen delivery and tissue oxygen demand, may provide a physiologic marker of cumulative metabolic stress during cardiopulmonary bypass (CPB). Adult LVAD-explant heart transplant recipients at a single center from October 2021 to June 2025 were analyzed using continuous perfusion data captured during CPB. Oxygen extraction ratio was calculated continuously, and cumulative oxygen extraction burden was quantified as the area above an O 2 ER threshold of 0.20. Patients were stratified by median O 2 ER burden. Among 110 patients, a higher intraoperative O 2 ER burden was associated with increased postoperative renal replacement therapy (odds ratio [OR], 4.16; 95% confidence interval [CI], 1.35–12.83) and increased 2-year mortality (hazard ratio [HR], 7.61; 95% CI, 1.49–38.73) after inverse probability weighting adjustment. A higher O 2 ER burden was also associated with a lower immediate postoperative cardiac index and increased vasoactive inotrope requirements. Donor hypertension, recipient diabetes, static storage modality, and a lower intraoperative oxygen delivery index were associated with an increased O 2 ER burden. These findings suggest that cumulative oxygen extraction during CPB reflects intraoperative metabolic stress and may represent a physiologically integrated perfusion target in LVAD-explant heart transplantation.
- 10 September 2026
- Published by Wolters Kluwer Health in Transplantation
- Vol. 110 (12) , e2359-e2360
Beating Heart Implantation—Added Pain, Little Gain?
Was not provided for this article.
- 10 September 2026
- Published by Wolters Kluwer Health in Transplantation
- Vol. 110 (12) , e2359-e2360
Beating Heart Implantation—Added Pain, Little Gain?
Was not provided for this article.
- Open Access
- 29 July 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (12) , 1910-1917
Tissue perfusion pressure as a physiologic indicator of renal failure risk after heart transplantation
- 29 July 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (12) , 1910-1917
Open AccessTissue perfusion pressure as a physiologic indicator of renal failure risk after heart transplantation
- 21 July 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (3) , 268-270
Rapid Ultraoxygenated Recovery Without Preimplant Reanimation Using Older Donation After Circulatory Death Heart Donors
- 21 July 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (3) , 268-270
Rapid Ultraoxygenated Recovery Without Preimplant Reanimation Using Older Donation After Circulatory Death Heart Donors
- 2 July 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Intraoperative Surface Echocardiography for Donor Heart Assessment During Normothermic Regional Perfusion
Heart transplantation continues to be the definitive treatment for end-stage heart failure, but organ availability limits access nationwide. Donation after circulatory death (DCD) hearts have shown tremendous promise as a viable avenue for expanding the donor pool. Still, the expanded utilization of DCD hearts has introduced new challenges that evaluating centers must work to address. Among these is the frequently variable and incomplete diagnostic information available on DCD donors before organ procurement. In this case report, we highlight the role of intraoperative surface echocardiography as a practical strategy for confirming organ suitability for transplant during DCD heart recovery with thoracoabdominal normothermic regional perfusion (TA-NRP). In specific circumstances where preoperative echocardiography is not feasible, but other diagnostic data support organ suitability for transplant, intraoperative surface echocardiography may serve as a valuable tool to increase organ utilization and improve access to life-saving transplantation.
- 2 July 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Intraoperative Surface Echocardiography for Donor Heart Assessment During Normothermic Regional Perfusion
Heart transplantation continues to be the definitive treatment for end-stage heart failure, but organ availability limits access nationwide. Donation after circulatory death (DCD) hearts have shown tremendous promise as a viable avenue for expanding the donor pool. Still, the expanded utilization of DCD hearts has introduced new challenges that evaluating centers must work to address. Among these is the frequently variable and incomplete diagnostic information available on DCD donors before organ procurement. In this case report, we highlight the role of intraoperative surface echocardiography as a practical strategy for confirming organ suitability for transplant during DCD heart recovery with thoracoabdominal normothermic regional perfusion (TA-NRP). In specific circumstances where preoperative echocardiography is not feasible, but other diagnostic data support organ suitability for transplant, intraoperative surface echocardiography may serve as a valuable tool to increase organ utilization and improve access to life-saving transplantation.